Review: Immunobiology of Preeclampsia

American Journal of Reproductive Immunology - Tập 37 Số 1 - Trang 79-86 - 1997
Robert N. Taylor1
1Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco School of Medicine, San Francisco, California 94143-0556

Tóm tắt

Preeclampsia has been recognized clinically since the time of Hippocrates: however its etiology and pathophysiology remain enigmatic. This pregnancy‐specific syndrome typically presents in late pregnancy as hypertension, edema, and proteinuria. Investigations over the past 15 years have revealed that preeclampsia is associated with abnormal placentation, reduced placental perfusion, endothelial cell dysfunction, and systemic vasospasm. Since it occurs more commonly in Primigravidae and in women with underlying collagen‐vascular diseases, an immunological component has long been suspected. Increased prevalence in high‐order and molar pregnancies and those associated with increased placental mass suggests that trophoblastic volume and fetal antigen load are correlated with the syndrome. Epidemiological reports indicate that the prevalence of preeclampsia is decreased in women who received heterologous blood transfusions, practiced oral sex, or when a long period of cohabitation preceded an established pregnancy. Conversely, the use of condoms as a primary mode of contraception is associated with a higher risk of preeclampsia. These studies suggest that prior exposure to foreign or paternal antigens imparts a protection against the likelihood of developing preeclampsia. Clinical evidence of cellular and humoral immune dysfunction is associated with the syndrome. Fibrin and complement deposition and “foam” cells in atherosis lesions resemble the histopathology of renal allograft rejection. Relative T‐cell, natural killer cell, and neutrophil activation have been reported in preeclampsia and circulating cytokines and antiphospholipid antibodies are more prevalent in preeclamptic than in normal pregnant women. These abnormalities are consistent with the systemic endothelial cell dysfunction that has been postulated as a pathophysiological feature of preeclampsia. While such associations do not prove causality, they suggest testable hypotheses for continued basic and clinical investigation of this major complication of human pregnancy.

Từ khóa


Tài liệu tham khảo

10.1016/0140-6736(93)90889-O

10.1016/0002-9378(95)90586-3

Eastman NJ., 1950, Williams Obstetrics

10.1016/0002-9378(95)90368-2

10.1016/0002-9378(80)90138-6

Brosens IA, 1972, The role of the spiral arteries in the pathogenesis of preeclampsia, Obstet Gynecol Annu, 1, 177

10.1016/0002-9378(73)90293-7

Dieckmann WJ., 1941, Factors influencing eclampsia in pregnant women, 250

10.1016/0165-0378(93)90032-D

10.1001/jama.1989.03430220066032

10.1016/S0140-6736(77)91199-0

Dekker GA., 1996, Oral tolerization to paternal antigens and preeclampsia, Am J Obstet Gynecol, 174, 450

10.1016/S0140-6736(94)91638-1

10.1097/00003081-199103000-00005

10.1111/j.1600-0897.1995.tb01135.x

10.1016/0002-9378(83)90332-0

Greer IA, 1991, Neutrophil activation is confined to the maternal circulation in pregnancy‐induced hypertension, Obstet Gynecol, 78, 28

10.1071/RD9890183

10.1111/j.1749-6632.1991.tb37850.x

10.1002/art.1780221119

Colbern GT, 1991, Immunology of the maternal‐placental interface in normal pregnancy, Semin Perinatol, 15, 196

10.1126/science.2326636

10.4049/jimmunol.154.8.3771

10.1016/0002-9378(89)90665-0

10.1111/j.1471-0528.1986.tb07830.x

10.1111/j.1471-0528.1991.tb13450.x

10.1006/scel.1993.1022

10.1016/S0002-9378(96)70245-4

10.1111/j.1471-0528.1993.tb15139.x

10.1161/01.CIR.75.5.956

10.1016/0090-6980(80)90010-6

10.1210/jcem-71-6-1675

10.1016/0002-9378(91)90317-K

10.1016/0002-9378(90)90385-K

10.1016/0002-9378(91)90435-T

10.1016/0002-9378(93)90151-8

10.1038/ki.1975.36

Shanklin DR, Ultrastructural aspects of preeclampsia. II. Mitochondrial changes, Am J Obstet Gynecol, 163, 943, 10.1016/0002-9378(90)91102-I

10.1172/JCI107462

10.1016/0002-9378(93)90389-Z

Kahaleh MB., 1990, The role of vascular endothelium in the pathogenesis of connective tissue disease: endothelial injury, activation, participation and response, Clin Exp Rheumatol, 8, 595

10.1016/0002-9378(79)90008-5

10.1111/j.1600-0897.1992.tb00794.x

Cutolo M., 1995, Estrogens, the immune response and autoimmunity, Clin Exp Rheumatol, 13, 217

10.1016/0002-9378(95)90033-0

10.1016/S0002-9378(94)70134-2

Lim KH, 1994, Differentiation of invasive cytotrophoblasts in normal and abnormal pregnancy, Soc Gynecol Invest, 42, 107A

10.1111/j.1471-0528.1995.tb11427.x

10.1016/0198-8859(94)90271-2

10.1111/j.1600-0897.1995.tb01137.x

10.1016/S0002-9378(88)80169-8

Tsukimori K., 1992, The possible role of endothelial cell in hypertensive disorders during pregnancy, Obstet Gynecol, 80, 229

10.1016/1071-5576(95)00052-6

10.1016/0002-9378(95)90112-4

10.1111/j.1600-0897.1992.tb00735.x

10.7326/0003-4819-119-8-199310150-00008

10.1002/jca.2920070102

10.1016/0002-9378(90)90836-V

Branch DW., 1990, Antiphospholipid antibodies and pregnancy: Maternal implications, Semin Perinatol, 14, 139

10.1111/j.1600-0897.1992.tb00753.x

10.1016/S0029-7844(95)80015-8

Carreras LO, 1982, Lupus” anticoagulant and thrombosis: Possible role of inhibition of prostacyclin formation, Thrombos Haemostas, 48, 38, 10.1055/s-0038-1657211

Tannenbaum SH, 1986, Antibody and immune complexes induce tissue factor production by human endothelial cells, J Immunol, 137, 1532, 10.4049/jimmunol.137.5.1532

10.1016/0049-3848(88)90104-1

10.1016/0002-9378(95)90030-6

10.1016/0952-3278(92)90112-V

10.1111/j.1365-2249.1994.tb06615.x

10.1111/j.1471-0528.1995.tb09020.x

10.1016/S0002-9378(12)91845-1

10.1111/j.1600-0897.1991.tb01075.x

10.1016/0002-9378(90)90761-U

Bertani T., 1989, Tumor necrosis factor induces glomerular damage in the rabbit, Am J Pathol, 134, 419

Jacobson PB, 1993, Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2, J Immunol, 151, 5639, 10.4049/jimmunol.151.10.5639

10.1172/JCI116860

Jendryczko A., 1990, Increased placental phospholipase A2 activities in preeclampsia, Zentralbl Gynakol, 112, 889

10.1016/0165-0378(95)00940-M

10.1016/0165-0378(85)90033-6

10.1111/j.1600-0897.1995.tb00918.x

Greer IA, 1994, Increased concentration of cytokines interleukin‐6 and interleukin‐1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction, Obstet Gynecol, 84, 937

Sudo N., 1993, Plasma endothelin‐1 and big endothelin‐1 levels in women with pre‐eclampsia, Acta Endocrinol (Copenh), 129, 114

10.1111/j.1471-0528.1992.tb14409.x

10.1042/cs0850417

10.1177/41.4.8450193

10.1172/JCI118447

10.1016/0167-4889(92)90033-8

Chesley LC., 1978, Hypertensive disorders in pregnancy, 777

10.1111/j.1471-0528.1986.tb08006.x

10.1136/bmj.303.6812.1241

Hayward C., 1992, An exclusion map for pre‐eclampsia: assuming autosomal recessive inheritance, Am J Hum Genet, 50, 749

10.3109/10641959309031050

10.1038/ng0593-59

10.1111/j.1471-0528.1990.tb02569.x

Redman CWG., 1991, Immunology of preeclampsia, Semin Perinatol, 15, 257

Ober C., 1992, The maternal‐fetal relationship in human pregnancy: An immunogenetic perspective, Exp Clin Immunol, 9, 1

10.1111/j.1399-0039.1990.tb01776.x

10.1159/000292531

10.1111/j.1600-0897.1994.tb00864.x

10.1046/j.1365-2249.1996.d01-647.x

10.1016/S0002-9378(94)70063-X

Thông tin
Thông tin xuất bản

American Journal of Reproductive Immunology

Tập 37 Số 1

79-86

Thông tin tác giả